Annual Drug Patent Expirations for SCEMBLIX
Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has seventy-nine patent family members in forty-nine countries.
The generic ingredient in SCEMBLIX is asciminib hydrochloride. One supplier is listed for this compound. Additional details are available on the asciminib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
